>
BREAKING: Congressman Troy Nehls Calls For Congressional Investigation Of FBI/CIA...
Could Israel Cease To Exist As A Nation-State In The Near Future,...
We Get Paid To Vaccinate Your Children
Economics, The State of Crypto, and The New Book #HijackingBitcoin
Blazing bits transmitted 4.5 million times faster than broadband
Scientists Close To Controlling All Genetic Material On Earth
Doodle to reality: World's 1st nuclear fusion-powered electric propulsion drive
Phase-change concrete melts snow and ice without salt or shovels
You Won't Want To Miss THIS During The Total Solar Eclipse (3D Eclipse Timeline And Viewing Tips
China Room Temperature Superconductor Researcher Had Experiments to Refute Critics
5 video games we wanna smell, now that it's kinda possible with GameScent
Unpowered cargo gliders on tow ropes promise 65% cheaper air freight
Wyoming A Finalist For Factory To Build Portable Micro-Nuclear Plants
It's a conundrum that has stumped scientists for centuries, but now researchers say they have taken a tantalising step forward in the quest to tackle the common cold.
The scourge of workplace, home and school playground, the common cold is predominantly caused by the rhinovirus. But attempts to thwart the pathogen by vaccination or antiviral drugs face a number of difficulties – not least because the virus comes in many forms and can mutate rapidly leading to drug resistance.
But now scientists say they have discovered a way to nobble the virus that could one day help those with conditions such as asthma and cystic fibrosis, for whom a cold is not merely a nuisance but a serious health risk.